GH Research Plc GHRS 深 滬
等待開盤 06-25 09:30:00 美东时间
24.60
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 24.60
- 總市值 16.88亿
- 52周最高 25.9399
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 11.32
- 委 比 0.00%
- 總股本 6860.89万
- 歷史最高 30.43
- 量 比 0
- 振 幅 0.00%
- 歷史最低 5.05
- 每 手 1
- 風險率 3.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多GH Research Announces Publication Of Full Results From Its Phase 2a Trial In Postpartum Depression
GH Research PLC (NASDAQ:GHRS) today announced the publication of the full results from its Phase 2a trial in postpartum depression (PPD) and the acceptance of two oral presentations at the 37th World Congress of
06-04 19:18
美股大行评级 | 最高1100美元，花旗、瑞穗、 Melius Research齐上调美光目标价；X-Energy获大小摩等多家机构首予“买入”评级
今日重点评级关注：TD Cowen：维持Strategy"买入"评级，目标价从395美元升至400美元；摩根士丹利：维持Cipher Digital"超配"评级，目标价从40.5美元升至42.5美元
05-20 11:55
美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
Citizens Maintains Market Outperform on GH Research, Lowers Price Target to $39
Citizens analyst Jason N. Butler maintains GH Research (NASDAQ:GHRS) with a Market Outperform and lowers the price target from $42 to $39.
05-15 20:03
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
GH Research Q1 EPS $(0.31) Misses $(0.28) Estimate
GH Research (NASDAQ:GHRS) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.28) by 10.71 percent. This is a 63.16 percent decrease over losses of $(0.19) per share from the
05-14 19:07
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Health officials explored restricting specific antidepressants among SSRI drugs-sourcesKennedy announced other steps to reduce use of the medicines on MondayKennedy says SSRIs are overprescribed and, without evidence,
05-09 00:02
GH Research Prices ~$117.5M Offering Of 6.528M Shares At $18/Share
GH Research PLC (NASDAQ:GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today announced the pricing of an
04-29 20:06
华盛早报 | 停火期限将至！美国单方面“敲定”谈判日，伊朗仍未点头赴会；沃什提名听证会演讲稿曝光
停火期限将至！美国单方面“敲定”谈判日，伊朗仍未点头赴会，纳指终结13连涨；沃什提名听证会演讲稿曝光，承诺货币政策严格独立；苹果官宣换帅！特纳斯将接替库克担任CEO>>
04-21 08:19
Enveric BioSciences Surges Over 90%, Other Psychedelic Stocks Soar In Monday Pre-Market: What's Going On?
Psychedelic drug maker shares jumped in Monday pre-market after an order from President Donald Trump to speed up psychedelic drug reviews
04-20 20:35
